Business Description
Bonus BioGroup Ltd
ISIN : IL0004850116
Total Employee Number:
42Description
Bonus BioGroup Ltd is a clinical-stage biotechnology company developing next-generation, cost-effective cell therapy solutions for various indications in regenerative medicine with prevalent and unmet clinical needs. The company is developing investigational cell therapy and tissue engineering solutions to address conditions involving tissue damage, bone loss, and inflammation. Its proprietary technology platform supports the clinical development of BonoFill and MesenCure.
Financial Strength
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.03 | |||||
Equity-to-Asset | -0.37 | |||||
Debt-to-Equity | -1.57 | |||||
Debt-to-EBITDA | -0.42 | |||||
Piotroski F-Score | 1/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | 17.9 | |||||
3-Year EPS without NRI Growth Rate | 5.2 | |||||
3-Year FCF Growth Rate | 26.8 |
Momentum Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 50.22 | |||||
9-Day RSI | 40.95 | |||||
14-Day RSI | 38.79 | |||||
3-1 Month Momentum % | -23.32 | |||||
6-1 Month Momentum % | -14.25 | |||||
12-1 Month Momentum % | 32.37 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 0.13 | |||||
Quick Ratio | 0.13 | |||||
Cash Ratio | 0.02 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
ROE % | -3788.09 | |||||
ROA % | -130.79 | |||||
ROIC % | -134.6 | |||||
3-Year ROIIC % | -203.51 | |||||
ROC (Joel Greenblatt) % | -163.15 | |||||
ROCE % | -308.52 | |||||
Moat Score | 3 | |||||
Tariff Resilience Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
EV-to-EBIT | -13.37 | |||||
EV-to-EBITDA | -15.12 | |||||
EV-to-FCF | -20.82 | |||||
Earnings Yield (Greenblatt) % | -7.49 | |||||
FCF Yield % | -4.83 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Bonus BioGroup Ltd Executives
DetailsGF Value™
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚Ş) | |||
| EPS (TTM) (â‚Ş) | -0.04 | ||
| Beta | 1.4383 | ||
| 3-Year Sharpe Ratio | 0.6 | ||
| 3-Year Sortino Ratio | 1.26 | ||
| Volatility % | 64.58 | ||
| 14-Day RSI | 38.79 | ||
| 14-Day ATR (â‚Ş) | 0.017589 | ||
| 20-Day SMA (â‚Ş) | 0.27825 | ||
| 12-1 Month Momentum % | 32.37 | ||
| 52-Week Range (â‚Ş) | 0.21 - 0.609 | ||
| Shares Outstanding (Mil) | 1,167.93 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 1 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Bonus BioGroup Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Bonus BioGroup Ltd Stock Events
| Event | Date | Price (â‚Ş) | ||
|---|---|---|---|---|
| 0.1:1 Stock Split | 2012-06-03 | 0.16 (+0.00%) |
Show
Entries
Bonus BioGroup Ltd Frequently Asked Questions
What is Bonus BioGroup Ltd(XTAE:BONS)'s stock price today?
The current price of XTAE:BONS is â‚Ş0.27. The 52 week high of XTAE:BONS is â‚Ş0.61 and 52 week low is â‚Ş0.21.
When is next earnings date of Bonus BioGroup Ltd(XTAE:BONS)?
The next earnings date of Bonus BioGroup Ltd(XTAE:BONS) is .
Does Bonus BioGroup Ltd(XTAE:BONS) pay dividends? If so, how much?
Bonus BioGroup Ltd(XTAE:BONS) does not pay dividend.
Press Release
| Subject | Date | ||
|---|---|---|---|
| ‏Bonus BioGroup's COVID Drug - MesenCure - Can Help a Life-threatening Complication Seen in Cancer Patients | 2022-04-28 |
Articles on Bonus BioGroup Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers